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Abstract
Background: Pain catastrophizing has been found to be an important predictor of disability and days lost from
work in patients with low back pain. The most commonly used outcome measure to identify pain catastrophizing
is the Pain Catastrophizing Scale (PCS). To enable the use of the PCS in clinical settings and research in
Norwegian speaking patients, the PCS had to be translated. The purpose of this study was therefore to translate and
cross-culturally adapt the PCS into Norwegian and to test internal consistency, construct validity and reproducibility
of the PCS.
Methods: The PCS was translated before it was tested for psychometric properties. Patients with subacute or chronic
non-specific low back pain aged 18 years or more were recruited from primary and secondary care. Validity of the
PCS was assessed by evaluating data quality (missing, floor and ceiling effects), principal components analysis,
internal consistency (Cronbach’s alpha), and construct validity (Spearman’s rho). Reproducibility analyses included
standard error of measurement, minimum detectable change, limits of agreement, and intraclass correlation
coefficients.
Results: A total of 38 men and 52 women (n = 90), with a mean (SD) age of 47.6 (11.7) years, were included for
baseline testing. A subgroup of 61 patients was included for test-retest assessments. The Norwegian PCS was easy-
to-comprehend. The principal components analysis supported a three-factor structure, internal consistency was
satisfactory for the PCS total score (α 0.90) and the subscales rumination (α 0.83) and helplessness (α 0.86), but not
for the subscale magnification (α 0.53). In total, 86% of the correlation analyses were in accordance with predefined
hypothesis. The reliability analyses showed intraclass correlation coefficients of 0.74− 0.87 for the PCS total score and
subscales. The PCS total score (range 0–52 points) showed a standard error of measurement of 4.6 points and a 95%
minimum detectable change estimate of 12.8 points.
Conclusions: The Norwegian PCS total score showed acceptable psychometric properties in terms of
comprehensibility, consistency, construct validity, and reproducibility when applied to patients with subacute or
chronic LBP from different clinical settings. Our study support the use of the PCS total score for clinical or research
purposes identifying or evaluating pain catastrophizing.
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Background
The Pain Catastrophizing Scale (PCS) was developed by
Sullivan et al.[1], and has been widely used in the re-
search of chronic pain and pain behavior in patients with
low back pain (LBP). Pain catastrophizing, explained as
an exaggerated negative orientation towards noxious
stimuli [1], has been found to correlate significantly to
pain severity, self-reported disability, pain behavior, fear
of movement and depression in patients with low back
pain (LBP) [1-5]. Furthermore, in chronic pain patients,
pain catastrophizing has been identified as an important
mediator to pain behavior and pain-related fear [6-8]. In
the cognitive-behavioral fear-avoidance model, presented
by Vlaeyen et al.[2], pain catastrophizing was found to
be the strongest predictor of fear of movement. Patients
who were fearful of movement performed worse in phys-
ical performance tests and were also more anxious after
the test was completed [2]. Moreover, pain catastrophiz-
ing and pain behavior have been found to predict days
lost from work and failure to return to work in subacute
and chronic LBP patients [9-12]. It has been recom-
mended that risk factors such as pain catastrophizing,
fear of movement, and distress should be identified early
and targeted in interventions specifically designed to re-
duce pain catastrophizing and fear [8,12,13]. A recent
cohort study in patients with work-related injuries found
that a reduction in catastrophic thinking and fear of
movement, over a 10-week intervention period, pre-
dicted return to work [3]. Thus, pain catastrophizing can
be reduced by targeted interventions and, importantly,
influence return to work.
To be able to evaluate interventions targeting pain cat-
astrophizing and investigate its significance in Norwe-
gian LBP populations, we translated and cross-culturally
adapted the English PCS [1] into Norwegian and tested
the Norwegian PCS for psychometric properties in terms
of validity and reproducibility in patients with LBP.
Methods
Study design
The study was carried out in a two-step procedure;
firstly, the PCS was translated and cross-culturally
adapted; and secondly, the Norwegian PCS was tested
for psychometric properties in a cross-sectional design
with a 1-week follow-up for test-retest.
Translation and cross-cultural adaptation
Translation and cross-cultural adaptation of the PCS
was performed according to international guidelines
[14,15]. Two persons (one clinician and one philologist),
whose mother tongue is Norwegian, independently
translated the original PCS into Norwegian. The two
Norwegian versions were synthesized into one Norwe-
gian version before it was translated back to English.
Two translators and native speaker of English, who were
blinded to the original PCS, performed the back-
translation. One expert committee consisting of the
translators, one health professional and the researchers
in our research group reviewed all translations. In a for-
mal meeting, the committee discussed discrepancies
until consensus on a prefinal version was achieved. The
goal of the prefinal Norwegian PCS was that it should be
as concise and easy to understand as possible. The first
4–5 patients with low back pain at each participating
clinic reviewed the prefinal Norwegian PCS. None of the
patients had difficulties in understanding the meaning of
items or responses. Since the prefinal version was highly
acceptable and easy-to-comprehend, no changes were
made and the final version of the Norwegian PCS was
equal to the prefinal. The English and Norwegian ver-
sions are presented in Additional file 1: Appendix.
Participants
A total of 103 participants were recruited from different
clinical settings in Oslo, Norway, between September
2008 and November 2009. Eligible participants were
patients with non-specific LBP for six weeks or more
prior to inclusion, aged 18 and over, and were able to
speak, read and write in Norwegian. Exclusion criteria
were sciatica or signs of ‘red flags’ (tumor, infection,
spinal fracture, or major neurologic compromise such as
cauda equina syndrome) [16]. The inclusion was per-
formed by a clinician, mostly a physical therapists, see-
ing the patients at their clinic. Four patients were
excluded because of signs of sciatica and nine patients
did not return the baseline questionnaires without giving
any reason for not participating. A total of 90 patients,
52 women and 38 men, were included; 30 patients from
three physical therapy clinics (primary care), 24 patients
from an outpatient rehabilitation clinic, six patients from
a pain unit (university hospital), and 30 patients from an
orthopaedic department (university hospital). Sixty-one
patients participated in the test-retest design, of whom
60 filled in the PCS at retest. Baseline characteristics of
the whole sample and the test-retest subgroup are pre-
sented in Table 1. All patients received written and oral
information about the study. Signed informed consent
was obtained from all patients. The study was approved
by the Norwegian Regional Committee for Medical Re-
search Ethics and the Data Inspectorate in 2008.
Procedures and measures
The included patients filled in the PCS, sociodemo-
graphic information, and concurrent measures at the
first attendance for assessment. Patients consenting to
participate at the retest filled in the PCS and a global
score (6-pointLikert scale) of change in LBP status
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between test and retest at the second attendance, prefer-
ably with a one-week interval.
The PCS
The PCS comprises 13 items focusing on thoughts and
feelings. The original PCS was evaluated in undergradu-
ate students and was found to be a reliable and valid
measure of catastrophizing with a three factor solution;
rumination (4 items), ruminative thoughts, worry, and
inability to inhibit pain-related thoughts; magnification
(3 items), magnification of the unpleasantness of pain
and expectancies for negative outcomes; and, helpless-
ness (6 items), inability to deal with painful situations [1].
Patients score the 13 items on a 5-point Likert scale,
ranging from 0 (not at all) and 4 (all the time), relating
the items to the past painful experience. Separate sub-
scores for the dimensions (range, rumination 0–16; mag-
nification 0–12; and helplessness 0–24 points) or a total
score (range, 0–52 points) can be calculated for the PCS.
A higher score indicates higher pain catastrophizing. In-
ternal missing values were replaced with mean values if
the number of missing items did not exceed two items,
except for analysis of data quality.
Concurrent measures
To assess construct validity, the PCS was compared with
outcome measures widely used and evaluated, which as-
sess physical functioning, fear avoidance, psychological
well-being and distress, quality of life, and pain. The Ro-
land Morris Disability Questionnaire (RMDQ) measures
pain related physical functioning [17], Core Outcome
Measures Index (COMI) is a short multi-dimensional
scale measuring the five most important domains relat-
ing to low back pain [18,19], Fear Avoidance Believes
Questionnaire Physical Activity subscale (FABQ-PA) and
Work subscale (FABQ-W) measure fear avoidance [20],
Table 1 Characteristics of the Study Sample; the Whole Sample (n =90) and the Sub-group Participating in Test-retest
(n = 60)
Whole
Sample
Test-retest
Sub-group
Mean (S.D.) or N (%)
Age (yrs.) 47.6 (11.7) 49.2 (11.2)
Sex (% Women) 52 (58%) 32 (52%)
Born in Norway (% yes) 80 (89%) 58 (95%)
Civil status
Single 21 (23%) 15 (25%)
Married/cohabiting 69 (77%) 46 (75%)
Work status
Employed 40 (44%) 24 (39%)
Sick-listed 18 (20%) 15 (25%)
Pension (disability, retired) 25 (28%) 18 (30%)
Pain localization
Lower back only 32 (36%) 23 (38%)
Lower back and other sites 57 (63%) 38 (62%)
Pain duration
Less than 3 months 19 (21%) 11 (18%)
3 months or more 71 (79%) 50 (82%)
Pain duration (yrs.) 9.7 (13.2) 11.0 (13.3)
Back pain Numeric Rating Scale (0–10) 4.8 (2.1) 4.9 (2.1)
Pain Catastrophizing Scale total score (0–52) 13.6 (9.2) 13.6 (8.9)
Roland Morris Disability Questionnaire (0–24) 7.6 (5.2) 7.2 (5.1)
Core Outcome Measure Index (0–10) 5.6 (1.9) 5.6 (1.8)
Fear Avoidance Beliefs Questionnaire, Physical Activity (0–24) 9.4 (5.5) 8.8 (5.3)
Fear Avoidance Beliefs Questionnaire, Work (0–42) 16.7 (11.9) 17.0 (11.2)
Hopkins Symptom Check List-25 (1–4) 1.61 (0.49) 1.64 (0.49)
EQ-5D 0.54 (0.31) 0.55 (0.29)
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Hopkins Symptom Check List-25 (HSCL-25) measures
anxiety, depression and somatization [21,22], EuroQol-5
Dimensions Index (EQ-5D) measures quality of life [23],
and the Numeric Rating Scale (NRS) measures back pain
[24].
Statistical analysis
Sample size was based on the quality criteria recom-
mended by Terwee et al.[25], who suggest a minimum
of 50 patients for assessing construct validity, reproduci-
bility, and floor or ceiling effects, and a minimum of 100
patients for assessing factor analysis and internal
consistency.
Descriptive analysis included mean (SD) and number
(%). Missing data and end effects were described. Floor
or ceiling effects were considered to be present if more
than 15% of the included sample scored the lowest or
the highest score, respectively [25].
Principal components analysis [26] was used to assess
the underlying structure of the PCS items. Components
were extracted with an eigenvalue greater than one. In-
ternal consistency was assessed by calculating the Cron-
bach’s alpha coefficient (α). A Cronbach’s alpha
coefficient between 0.70 and 0.95 has been considered
acceptable homogeneity [25].
The construct validation of the PCS total score was
assessed by comparing the PCS for association to con-
current measures. Predefined hypotheses of association
were established based on the construct of the measures.
Hence, we expected measures of psychological con-
structs, i.e. the FABQ and the HCSL-25, to have moder-
ate to high correlation to the PCS. Whereas measures of
other constructs, i.e. the RMQD, COMI, EQ-5D, and
NRS back pain, were expected to have low to moderate
correlation to the PCS. All correlation coefficients, ex-
cept for the EQ-5D, were expected to correlate positively
to the PCS. The EQ-5D was expected to correlate nega-
tively to the PCS, as scaling has an inverse relationship.
Normality and linearity assessments were performed for
the included variables. Assumption of linear relation-
ship could not be confirmed. Hence, construct validity
was assessed by the Spearman’s rank order correlation
coefficients (rho). High correlations were equivalent to
correlation coefficients of rho ≥ 0.60, moderate to rho
<0.60 – ≥0.30, and low to rho< 0.30 [27]. An adequate
construct validity of the PCS was achieved if 75% or
more of the results were in correspondence with the
predefined hypothesis [25].
Reproducibility was analyzed by reliability and agree-
ment parameters and applied to the total score and sub-
scales of the PCS. Main analysis was performed on the
whole sample participating at test and retest. A supple-
mentary analysis was conducted in patients reporting a
stable (unchanged) status between test and retest.
Reliability was tested by applying the intraclass
correlation coefficient (ICC) consistency formula
[ICCconsistency = σpatients
2 /σpatients
2 + σresidual
2 ] [28] and its
95% confidence interval (CI). Agreement was tested by
the standard error of measurement (SEM) consistency
formula [SEMconsistency = √ σresidual
2 ] [28]. The error vari-
ance (within people residual mean square) was extracted
from an ANOVA analysis. The 95% confidence level of
the minimum detectable change (MDC95) was calculated
to evaluate the smallest within-person change in score by
calculating the formula [MDC95 = 1.96 × √2 × SEM] [28].
The MDC95 has been described as a “real” change, if
above measurement error and p< 0.05, in one individual
[25]. In addition, the percentage of the MDC in relation
to the maximum score was calculated. As described by
Bland & Altman, scatter plots of intraindividual differ-
ence between test and retest against the grand mean
[meantest1 +meantest2/2] were generated. Limits of agree-
ment (95%) were calculated by the formula [mean differ-
ence ± 1.96 × SDdifference] [29]. The statistical package
SPSS 16.0 for Windows, Release 16.0.2 (IBMW SPSSW
Statistics, NY) was used for all analyses.
Results
Data quality
Overall, patients were able to complete the PCS without
assistance. Nine patients had a total of 21 internal miss-
ing values. Missing values were spread over 12 out of 13
items. Item 1 ‘I worry all the time whether the pain will
end’ had no missing value. The median PCS total score
was 12 points (range, 0 to 37 points). Floor effects were
seen in 12 out of 13 items, but not for PCS total score
or subscales. No ceiling effects were found. Data quality
is presented in Table 2.
Factor analysis and internal consistency
The principal components analysis revealed a three-
factor structure, which accounted for 64.5% of the total
variance (Table 3). The items loading on the first com-
ponent (item 11, 10, 8, 9, 6) had loadings ranging from
0.57 to 0.79, the second component (item 13, 1, 7) from
0.52 to 0.89, and the third component (item 12, 4, 2, 5,
3) from 0.54 to 0.87, respectively. The first component
accounted for 47.9% of the total variance, whereas com-
ponent two and three accounted for 8.1% and 8.8%, re-
spectively. The internal consistency, assessed by
Cronbach’s alpha, was 0.90 for the total score and 0.86,
0.63, and 0.83 for the three subscales according to
current factor structure revealed in this material. When
using the same three-factor structure as in the original
study, the Cronbach’s alpha for the first and third com-
ponents were highest with values of 0.86 for the helpless-
ness subscale and 0.83 for the rumination subscale. The
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magnification subscale had a Cronbach’s alpha of only
0.53.
Construct validity
The PCS total score showed moderate correlation coeffi-
cients to the FABQ-PA (rho = 0.34) and HSCL-25 (rho =
0.56), as well as to the COMI (rho = 0.43), EQ-5D (rho =
−0.36), and NRS back pain (rho = 0.31). Moreover, the
PCS total score correlated low to the RMDQ (rho = 0.27)
and FABQ-W (rho = 0.25) (Table 4). In total, 86% of the
a priori hypotheses were confirmed.
Reproducibility
The median time between test and retest was 7 days
(range, 1–30 days). The PCS total score showed a mean
(SD) of 13.6 (8.9) and 14.1 (9.5) points at test and retest,
respectively, and an ICC (95% CI) between tests of 0.85
(0.76, 0.91). The SEM of the PCS total score was 4.6
points and the MDC95 12.8 points. Reproducibility data
of the PCS total score and subscales are presented in
Table 5. The mean difference between test and retest
was 0.7 points, on the PCS total score, with limits of
agreement of 13.5 and −12.1 points (Figure 1). Thirty-
five patients scored “no change” in LBP status between
test and retest, of whom 34 had filled in the PCS twice.
Supplementary analyses of stable patients (n = 34)
showed slightly higher ICCs and somewhat lower SEMs
and MDCs (Table 6).
Discussion
This study demonstrated that the Norwegian PCS was
comprehendible, easily administered and, overall, held
acceptable psychometric standards when assessed in
patients with non-specific LBP recruited from different
clinical settings. The PCS total score appeared to be
more robust than the subscales alone. We suggest that
the Norwegian PCS total score can be used in clinical
settings and research in patients with non-specific LBP
across different settings for purposes evaluating pain
catastrophizing.
The principal components analysis supported a three-
factor structure similar to the original study of Sullivan
et al.[1]. Also later studies support this finding [30-32].
There were minor differences with respect to which
items that loaded on the three components, however.
This is also similar to what is reported in other studies
that have validated the PCS [30,32]. We found a slightly
better fit for factor structure with item 6 in the rumin-
ation subscale than in the magnification subscale (as in
the original model) and with item 1 in the magnification
subscale than in the helplessness subscale. The differ-
ences across the studies might be due to differences in
patient samples. As suggested by Meyer et al.[32], the
PCS scores should be reported according to the sub-
scales and the total score as recommended by Sullivan
et al. in the original study [1]. Otherwise, it will be im-
possible to compare the results across studies using dif-
ferent item solutions in the different components. The
Table 2 Internal missing values (n = 90 patients × number of items) and N (%) scoring the lowest or highest score on
the Pain Catastrophizing Scale (n =90). Higher score indicating higher degree of pain catastrophizing
Pain Catastrophizing Scale Range Internal
missing
N (%)
Mean
(S.D.)
Lowest
N (%)
Highest
N (%)
Total score 0− 52 21 (0.02) 13.6 (9.2) 3 (3.3) 0
Rumination subscale 0− 16 7 (0.02) 5.0 (3.5) 6 (6.7) 0
8 I anxiously want the pain to go away 0− 4 1 (0.002) 1.9 (1.3) 16 (17.8) 9 (10.0)
9 I can’t seem to keep it out of mind 0− 4 2 (0.005) 0.8 (0.9) 40 (44.4) 2 (2.2)
10 I keep thinking about how much it hurts 0− 4 2 (0.005) 0.8 (0.8) 35 (38.9) 0
11 I keep thinking about how badly I want the pain to stop 0− 4 2 (0.005) 1.6 (1.3) 20 (22.2) 9 (10.0)
Magnification subscale 0− 12 4 (0.01) 2.8 (2.0) 12 (13.3) 0
6 I become afraid that the pain may get worse 0− 4 2 (0.007) 1.6 (1.2) 16 (17.8) 5 (5.7)
7 I think of other painful experiences 0− 4 1 (0.004) 0.4 (0.7) 63 (70.0) 0
13 I wonder whether something serious may happen 0− 4 1 (0.004) 0.7 (0.9) 47 (52.2) 1 (1.1)
Helplessness subscale 0− 24 7 (0.02) 6.2 (4.8) 6 (6.7) 1 (1.1)
1 I worry all the time whether the pain will end 0− 4 0 1.5 (1.1) 15 (16.7) 4 (4.4)
2 I feel I can’t go on 0− 4 2 (0.004) 0.9 (1.1) 43 (47.8) 1 (1.1)
3 It’s terrible and I think it’s never going to get any better 0− 4 1 (0.002) 1.1 (1.1) 33 (36.7) 3 (3.3)
4 It’s awful and I feel that it overwhelms me 0− 4 3 (0.006) 0.8 (1.1) 46 (51.1) 2 (2.2)
5 I feel I can’t stand it any more 0− 4 1 (0.002) 0.8 (1.1) 52 (57.8) 3 (3.4)
12 There is nothing I can do to reduce the intensity of the
pain
0− 4 3 (0.006) 1.2 (1.0) 23 (25.6) 1 (1.1)
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internal consistency, according to the current factor
structure found in our study and the original structure,
showed acceptable homogeneity (α 0.83–0.90) for the
subscales rumination and helplessness and the total
score. Earlier studies have shown acceptable homogen-
eity for the total score and all subscales in both clinical
and nonclinical samples and have suggested that the
PCS can be used as one score (13 items) or as three sep-
arate scores independently [1,30,31,33]. Based on the
results in our study, the magnification subscale did not
show an acceptable internal consistency (α 0.63 and
0.53) and, on the contrary to earlier studies, we cannot
suggest the independent use of it. Evidence was found
for construct validity, since 86% of the results in the cor-
relation analysis were in accordance with predefined hy-
pothesis. The hypotheses were based on existing
literature of the PCS and its relation to different aspects
of health, e.g. more catastrophizing thoughts has been
found to be associated with more distress, disability and
fear avoidance beliefs [1,5,32]. Higher associations have
been found for variables measuring psychological
aspects of health compared with variables measuring
physical aspects of health. The PCS showed, as pre-
sumed, higher correlation coefficients to concurrent
measurements of psychological constructs (e.g. distress
by HSCL-25) as compared to outcomes of other con-
structs such as disability, pain and health related quality
of life. However, the PCS correlated lower than expected
to the FABQ-W and showed a lower correlation coeffi-
cient compared to one previous study (rho = 0.25 versus
r = 0.61) [32]. This result might be explained by the fact
that the FABQ-W has specific questions related to work
and only 40 patients (44%) in our study were employed.
The rate of employed in the study by Meyer et al.[32]
was not described. The correlation between the PCS and
pain severity was in our study found to be lower than in
earlier published articles (rho 0.31 versus r = 0.41− 0.55)
[1,3-5], but in correspondence to the earlier studies the
correlation coefficient was significant.
The reliability of the Norwegian PCS showed high
ICCs (above 0.70) for both total score and subscales
(Table 5). Hence, the Norwegian PCS has the potential
to discriminate between patients with different levels of
catastrophizing [28]. Though, for PCS total scores above
37 points we could not ascertain the reliability since the
score ranged from 0 to 37 points in the included sample.
Table 3 Pain Catastrophizing Scale factor structure by Principal Components Analysis with loadings (n =90)
Pain Catastrophizing Scale Components
Rumination Magnification Helplessness
11 I keep thinking about how badly I want the pain to stop 0.79
10 I keep thinking about how much it hurts 0.78
8 I anxiously want the pain to go away 0.72
9 I can’t seem to keep it out of mind 0.67 0.43
6 I become afraid that the pain may get worse 0.57 0.32
13 I wonder whether something serious may happen 0.89
1 I worry all the time whether the pain will end 0.49 0.61
7 I think of other painful experiences 0.37 0.52
12 There is nothing I can do to reduce the intensity of the pain 0.87
4 It’s awful and I feel that it overwhelms me 0.60 0.64
2 I feel I can’t go on 0.33 0.63
5 I feel I can’t stand it any more 0.57 0.61
3 It’s terrible and I think it’s never going to get any better 0.52 0.54
Extraction Method: Principal Component Analysis; varimax rotation with Kaiser normalization. Rotation converged in six iterations; values below 0.3 are
suppressed. The model explained 64.7% of the total variance; component 1 explained 47.9%, component 2 = 8.1%, and component 3 = 8.8%.
Table 4 Predefined Hypothesis of Correlation and
Spearman’s rho Coefficients for the PCS Total Score and
Concurrent Measures (n =90)
Correlation
coefficient (rho)
Hypothesis
confirmed yes/no
Moderate to high correlation
FABQ-PA 0.34** Yes
FABQ-W 0.25* No
HSCL-25 0.56** Yes
Low to moderate correlation
RMDQ 0.27* Yes
COMI 0.43** Yes
EQ-5D -0.36** Yes
NRS back pain 0.31** Yes
*p< 0.05 (two-tailed)
**p< 0.01 (two-tailed)
FABQ-PA: Fear Avoidance Believes Questionnaire Physical Activity; FABQ-W:
Fear Avoidance Believes Questionnaire work; HSCL-25: Hopkins Symptom
Check List-25; RMDQ: Roland Morris Disability Questionnaire; COMI: Core
Outcome Measures Index; EQ-5D: EuroQual-5 Dimensions Index; NRS: Numeric
Rating Scale.
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Compared to studies including patients with LBP
[31,33,34], our sample had lower mean scores (mean
PCS total score 20–30 versus 14 points). One possible
reason for a lower mean score in our sample may be the
inclusion of patients with subacute LBP, as opposed to
commonly seen inclusion criteria of chronic LBP only.
Recalling that pain catatrophizing has been discussed as
one mediator of chronicity of symptoms [6-8] and is a
predictor of failure to return-to-work [9-12], pain cata-
strophizing thoughts has been suggested to be identified
early to better target interventions [8,12]. In our sample,
21% could be defined as patients who seek health care
“early” (pain duration of <3 months) and, therefore, may
score lower on the PCS compared to a sample including
chronic pain patients only.
Main strengths of the present study were, as far as our
design allowed, the inclusion of psychometric properties
for the evaluation of health status questionnaires as
recommended by Terwee et al.[25]. This study is among
the first to include agreement analyses for the PCS. In
medical research evaluating interventions targeting pain
catastrophizing thoughts, agreement properties of out-
come measures estimating potential effect are of import-
ance [28]. Our study showed that the PCS total score
held superior agreement as compared to the individual
subscales (Table 5 and 6). Compared to two earlier stud-
ies, the MDC95 in our study (12.8 points) was equal to
the findings of Meyer et al. (12.8 points) [32], but higher
than the findings of Georg et al. (9.1 points) [35]. The
percentage of the MDC95 in relation to the maximum
score for the PCS total score was 25%. Subsequently, an
individual has to change 25% on the PCS total score be-
tween pre- and post-intervention to exceed measure-
ment error and its 95% CI and to be classified as having
Table 5 Test-retest Statistics of the Pain Catatstrophizing Scale (n =60)
Mean (S.D.) Mean (S.D.) ICC (95% CI) SEM MDC95 MDC%
test retest
Total score (0–52) 13.6 (8.9) 14.1 (9.5) 0.85 (0.76, 0.91) 4.6 12.8 24.6
Rumination (0–16) 5.0 (3.4) 5.2 (4.0) 0.74 (0.56, 0.84) 2.4 6.7 41.6
Magnification (0–12) 2.7 (2.2) 2.6 (2.3) 0.82 (0.70, 0.89) 1.2 3.5 29.0
Helplessness (0–24) 5.9 (4.3) 6.3 (4.1) 0.87 (0.78, 0.92) 2.0 5.6 23.3
ICC: Intraclass correlation coefficient; SEM: standard error of measurement. MDC: minimum detectable change.
SEMconsistency = √Within people Residual Mean square.
MDC95 = 1.96 × √2 × SEM.
MDC %=MDC as percentage of maximum sore.
Figure 1 Scatter plot of intraindividual difference between test and retest against the grand mean of the total score of the Norwegian
Pain Catastrophizing Scale (n = 60).
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a “real” change in pain catastrophizing score. To fully in-
terpret our agreement analyses, the SEMs and MDCs
need to be compared to minimum important changes,
rated by patients’ opinion, which can be performed in
responsiveness analyses [25]. One study of responsive-
ness found a high standardized response mean (SRM
1.12) for the PCS, suggesting that the PCS can capture
change over time, but no analyses of minimum import-
ant changes were performed [36]. Further investigations
of minimum important change of the PCS would there-
fore be needed. The median number of days between
tests was seven days, though, the range between tests
was one to 30 days. Recall bias is a potential risk for
patients seeing the clinician with a short interval and
change in LBP status is a risk when the time lapse be-
tween tests is long. To avoid potential recall bias, the
PCS was part of a comprehensive assessment packet
both at test and retest and it was filled in after attend-
ance at both test and retest. One clear limitation in our
study was that 25 of 60 patients who participated in the
test-retest assessment scored “change” in LBP status be-
tween test and retest. For that reason we completed sup-
plementary analyses of the 35 “stable” LBP patients. The
reproducibility analysis of the 35 stable LBP patients
showed slightly better results (compare Table 5 and 6).
Another limitation was sample size. Our sample size for
the principal components analysis was 90 patients,
which is less than 100 or 150 participants recommended
for factor analysis [25,26].
Conclusion
The Norwegian PCS total score shows evidence for ac-
ceptable psychometric properties in terms of being fully
comprehensible, internally consistent, reproducible, and
comprising a valid construct when applied in patients with
subacute or chronic LBP from different clinical settings,
but internal consistency and agreement was questionable
for the individual subscales. Our study supports the use of
the PCS total score for clinical or research purposes iden-
tifying or evaluating pain catastrophizing. Further investi-
gations of responsiveness of the PCS are suggested.
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